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Objectives. This study was undertaken to determine the preva- 
lence of carotid atherosclerosis n a large group of asymptomatic 
hypertensive and normotensive adults and to examine its relation 
to the presence of left ventrieular hypertrophy. 
Background. Both electrocardiographic and echocardiographic 
left ventricular hypertrophy predict an increased risk of cardio- 
vascular events and mortality, including cerebrovascular disease, 
but the mechanism of association is unknown. 
Methods. Four hundred eighty-six (277 normotensive and 209 
untreated hypertensive) adults, free of clinical evidence of cardio- 
vascular disease, were studied prospectively with echocardiogra- 
phy to determine left ventricular mass and carotid ultrasound to 
detect atherosclerosis and to measure common carotid artery 
dimensions. 
Results. Carotid atherosclerosis was present in 16% of normo- 
tensive and 23% of hypertensive participants (p < 0.05) and was 
associated with older age, higher systolic and pulse pressures and 
larger left ventricular mass index ([mean _+ SD] 91 + 19 vs. 82 + 
18 g/m 2, p < 0.0001). The difference in mass persisted after 
adjustment for baseline differences in age and blood pressure. 
Subjects with left ventricular hypertrophy were twice as likely to 
have carotid atheromas (35% vs. 18%, p < 0.01). Logistic regres- 
sion analyses, including standard risk factors, indicated that only 
age and left ventricular mass index independently predicted the 
presence of carotid plaque, both in the entire study group and 
when normotensive and hypertensive subjects were considered 
separately. 
Conclusions. We believe that the present study provides the 
first evidence that higher left ventricular mass as detected by 
echocardiography is associated with the presence of carotid 
plaque. The association between cardiac hypertrophy and sys- 
temic atherosclerosis may contribute to the pathogenesis of the 
high incidence of vascular events that is well documented in 
patients with left ventricular hypertrophy. 
(J Am Coll Cardiol 1995;25:83-90) 
The predictive value of both electrocardiographic (ECG) (1) 
and, as a more sensitive measure, echocardiographic (2) 
evidence of left ventricular hypertrophy for subsequent cardio- 
vascular morbidity and mortality is well established in the 
general population (3), among hypertensive patients (2,4,5) 
and among catheterized patients with or without coronary 
artery disease (6,7). Progress has been made in elucidating 
mechanisms underlying the relation between left ventricular 
hypertrophy and complications from ischemic heart disease, 
including impairment of coronary vascular reserve (8-11), 
more extensive coronary atherosclerosis (12), an increased risk 
of ventricular arrhythmias (13-15) and greater susceptibility of
hypertrophied myocardium to ischemic damage (16). 
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Additional observations have documented a relation be- 
tween ECG (17) or echocardiographic (18) left ventricular 
hypertrophy and the subsequent risk of stroke. Recent longi- 
tudinal data from the Framingham Study (18) demonstrate a 
stepwise increase in the risk of transient ischemic attack and 
stroke by quartile of left ventricular mass indexed by height 
independent of blood pressure, serum lipids and smoking 
history in both men and women. Although the mechanism of 
this association is unknown, indirect ECG evidence of left 
ventricular hypertrophy was found to be associated with in- 
creased carotid wall thickness and more prevalent carotid 
stenoses among elderly subjects participating in the Cardiovas- 
cular Health Study (19). Available studies have not evaluated 
the possible association between the more sensitive echocar- 
diographic measurement of left ventricular mass and the 
presence of atherosclerosis in the carotid circulation, which is 
now amenable to noninvasive study. 
Preliminary data from our laboratory (20) have identified 
an increased prevalence of carotid atherosclerosis in subjects 
with echocardiographic left ventricular hypertrophy indepen- 
dent of standard risk factors. Thus, the present study was 
undertaken to determine the prevalence of carotid atheroscle- 
rosis in a large group of asymptomatic hypertensive and 
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normotensive adults and to examine its relation to the pres- 
ence of left ventricular hypertrophy. 
Methods  
Study subjects. The study included 486 adults: 277 normo- 
tensive subjects from employed populations enrolled by de- 
fined recruitment schemes into ongoing longitudinal studies 
(21,22) and 209 untreated hypertensive patients from either 
the work site-based studies or referred from the Hypertension 
Center of The New York Hospital-Cornell Medical Center. 
One hundred forty-nine patients had essential hypertension 
(systolic pressure >140 mm Hg or diastolic pressure 
->90 mm Hg); 43 had borderline or "white coat" hypertension 
(elevated clinical blood pressure with normal ambulatory 
blood pressure [awake blood pressure <134/90 mm Hg (23)]); 
and 17 had isolated systolic hypertension (systolic pressure 
>-160 mm Hg and diastolic pressure <90 mm Hg). All 486 
subjects were asymptomatic and free of clinical evidence of 
coronary artery or cerebrovascular disease. The presence of 
valvular heart disease was excluded by Doppler echocardiog- 
raphy. Eighty-three hypertensive patients (40%) had never 
received pharmacologic antihypertensive therapy; the remain- 
ing 126 patients were studied without medication for periods of 
3 weeks to several years. The study was performed in accor- 
dance with protocols approved by the Committee on Human 
Rights in Research of Cornell University Medical College. 
Echocardiography. All subjects underwent M-mode, two- 
dimensional and Doppler echocardiography performed by a 
research technician using commercially available chocardio- 
graphs equipped with 2.5- and 3.5-MHz transducers. Left 
ventricular dimensions were obtained from two-dimensionally 
guided M-mode tracings according to recommendations f the 
American Society of Echocardiography (24). Studies were 
coded and read in batches that mixed tracings for normoten- 
sive and hypertensive subjects, with no information about 
subject age, gender, blood pressure or body size. Measure- 
ments were performed for up to six cycles using a digitizing 
tablet and were averaged. Left ventricular mass was calculated 
using the Penn convention (25). Whenever M-mode cycles 
were unsuitable, left ventricular measurements were obtained 
from the two-dimensional study using the approach recom- 
mended by the American Society of Echocardiography (26). 
Left ventricular hypertrophy was considered present if the left 
ventricular mass indexed by body surface area exceeded 125 
g/m ~ in men or 110 g/m 2 in women (2,4,27). The 95% 
confidence interval of reproducibility of left ventricular mass 
measurement performed 5 years apart in 117 normotensive 
adults was _+23 g after adjustment for biologic influences of 
changes in weight, blood pressure and dietary salt intake (28). 
Carotid ultrasound. Imaging of both carotid arteries was 
performed in all subjects using a Biosound Genesis II system 
(OTE Biomedica, Florence, Italy) equipped with a 7.5-MHz 
imaging transducer. With the subject supine with slight hyper- 
extension of the neck, the common carotid artery, carotid bulb 
and bifurcation were identified. The carotid bulb and proximal 
Figure 1. Two-dimensional image of the distal common carotid artery 
(CC), carotid bulb and bifurcation i a 60-year old woman. An 
atherosclerotic plaque 2.6 mm in maximal thickness i  highlighted by
the arrows; distal common carotid wall thickness was 0.7 mm. EC = 
external carotid artery; IC = internal carotid artery. 
portions of the external and internal carotid arteries were 
imaged in multiple projections to maximize detection of irreg- 
ularities in the vessel walls. Carotid atherosclerosis was defined 
as the presence of a discrete plaque at least 50% greater than 
the surrounding wall within any segment of either carotid 
artery (29). Carotid plaque size was quantified by computer- 
assisted measurement of plaque thickness on two-dimensional 
frames (Fig. 1). 
Two-dimensionally guided M-mode tracings of the distal 
common carotid artery -1 cm proximal to the bulb were 
recorded on 0.5-in. videotape, as previously described (30). 
The videotape was subsequently reviewed, and suitable frames 
for measurement of M-mode images were obtained in real 
time using a frame grabber (Imaging Technology, Inc.) inter- 
faced with a high resolution (640 x 480 pixel) video monitor 
and stored on diskettes. The axial resolution of the M-mode 
system is 0.2 mm. 
All carotid measurements were performed on stored im- 
ages using a mouse-driven computer program after calibration 
for depth. Measurements included end-diastolic (minimal di- 
ameter) wall thickness, defined as the combined thickness of 
the apparent intimal-medial layers of the far wall (31), and 
end-diastolic and peak-systolic (maximal diameter) internal 
dimensions obtained by continuous tracing of the intimal- 
luminal interface of the near and far walls of the common 
carotid artery (Fig. 2). All measurements were performed over 
several cycles and averaged. The ultrasound measurement of 
carotid wall thickness has been validated by Pignoli et al. (31) 
and Gamble et al. (32) using gross and histopathologic refer- 
ence standards. In our laboratory, reproducibility of carotid 
wall thickness measurements has been shown to be high with 
regard to both intraobserver ( = 0.98, SEE 0.04 mm) and 
interobserver ( = 0.97, SEE 0.05 ram) variabilities (30). Wall 
thickness of the distal common carotid artery was never 
measured at the level of a discrete plaque. 
JACC Vol. 25, No. 1 ROMAN ET AL. 85 
January 1995:83-90 CAROTID PLAQUE AND VENTRICULAR HYPERTROPHY 
Figure 2. Two-dimensionally guided M-mode ultrasound 
tracing of the distal common carotid artery in a 68-year 
old man. Top, Intimal-medial thickness of the far wall 
(indicated between the red arrows) measured at end- 
diastole (minimal diameter). Bottom, Continuous tracing 
of intimal-luminal interfaces of the near and far walls to 
detect minimal and maximal diameters i indicated by the 
red lines. Depth markers are I cm apart. 
Statistical methods. Data were analyzed with the Crunch 4
Statistical Package (Crunch Software Corp.). Mean values are 
presented with 1 SD as the index of dispersion and were 
compared by the Student t test. Differences in prevalences 
between two groups were compared by a chi-square test with 
the Yates continuity correction. Significant differences in base- 
line variables between groups with and without plaque were 
taken into account by means of analysis of covariance. Inde- 
pendent predictive effects of risk factors for plaque were 
determined using logistic regression analysis. 
Resu l ts  
Subject characteristics. Clinical characteristics of the nor- 
motensive and hypertensive subgroups are compared in Table 1. 
Hypertensive subjects were significantly older, more likely to be 
women and more overweight. There was a more than threefold 
increase in the prevalence of left ventricular hypertrophy (using 
gender-specific criteria) among the hypertensive group as well as 
an increased prevalence of carotid plaque. 
Carotid atheroselerosis was present in 19% of subjects, and 
the clinical features of the 94 subjects with plaque are corn- 
pared with those of the 392 subjects without plaque in Table 2. 
Subjects with plaque were significantly older, more likely to be 
hypertensive, had higher systolic and pulse pressures and 
exhibited a strong trend (p = 0.06) toward a higher prevalence 
of current or former cigarette smoking than those without 
plaque. The two groups were similar with regard to diastolic 
pressure and serum lipid levels. 
Plaque was present in 21.6% of women and 18.5% of men. 
The similarity in prevalence may reflect the offsetting influ- 
ences of differences in risk factors, with women being older 
(56 +_ 14 vs. 50 -+ 12 years, p < 0.00005) and more likely to be 
hypertensive (52% vs. 39%, p < 0.01) than men but having 
higher high density lipoprotein levels (61 vs. 51 mg/dl, p < 
0.00005) and a similar smoking history. 
Relation of carotid plaque to cardiac and vascular geome- 
try. Absolute and relative left ventricular and common carotid 
wall thicknesses were greater in the group with carotid athero- 
sclerosis (Table 3). Left ventricular mass and, more significantly, 
left ventricular mass index were accordingly larger. After adjust- 
ment for baseline differences in age and systolic blood pressure 
between the two groups using analysis of covariance, significant 
differences persisted in left ventricular (0.90 vs. 0.86 cm, p < 0.05) 
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Table 1. Clinical Features of Subjects With and Without Hypertension 
Normotensive Hypertensive 
Subjects Subjects 
(n = 277) (n = 209) 
P 
Value 
Age (yr) 49 ± 12 56 ± 13 < 0.00005 
Gender (% male) 72 60 < 0.01 
Race (% white) 77.5 80 NS 
Body surface area (m z) 1.88 ± 0.21 1.89 ± 0.23 NS 
Body mass index (kg/m 2) 25.8 ___ 4.0 26.6 ± 4.3 < 0.05 
Blood pressure (mm Hg) 
Systolic 121 ± 12 156 + 22 < 0.00005 
Diastolic 74 ± 8 92 ± 11 < 0.00005 
Pulse 47 ± 9 63 _+ 18 < 0.00005 
Creatinine (mg/dl) 1.0 + 0.2 1.0 _+ 0.2 NS 
Glucose (mg/dl) 84 ± 22 89 -- 31 NS 
Total cholesterol (mg/dl) 220 ___ 41 225 _+ 46 NS 
HDL cholesterol (mg/dl) 54 ± 16 55 _+ 16 NS 
Smoking (%) NS (0.25) 
Former 33 34 
Current 14 9 
Left ventricular hypertrophy (%) 4 14 < 0.005 
Carotid plaque (%) 16 23 < 0.05 
Data presented are mean value _+ SD or percent of patients. HDL = high density lipoprotein. 
and carotid (0.82 vs. 0.77 mm, p < 0.05) wall thicknesses and in 
left ventricular mass (168 vs. 155 g, p < 0.01) and mass index (88 
vs. 82 g/m e, p < 0.01). There was a twofold increase in the 
prevalence of carotid atherosclerosis among subjects with left 
ventricular hypertrophy compared with those without (35% vs. 
18%, odds ratio 2.47 [95% confidence interval 1.08 to 4.94], p < 
0.01) (Fig. 3). In a logistic regression analysis that included age, 
blood pressure, serum cholesterol, smoking history and left 
ventricular mass in the equation, only age (p = 0.00005), left 
ventricular mass (p = 0.005) and current smoking (p = 0.05) were 
independently related to the presence of carotid atherosclerosis 
(Table 4). 
Subdivision of the subjects into quintiles of left ventricular 
mass index (Fig. 4) suggested a continuous relation between 
left ventricular mass and the likelihood of carotid atheroscle- 
rosis rather than a threshold effect. Consistent with this 
interpretation, left ventricular hypertrophy, defined as a cate- 
goric variable, did not add significantly (p = 0.3) to the 
predictive value of age for the presence of carotid plaque in a 
similar logistic regression analysis. 
Associations with plaque in normotensive and hypertensive 
subjects. Among normotensive subjects, those with plaque 
(n = 45) differed from those without plaque (n = 232) in age 
(60 _+ 12 vs. 46 _ 11 years, p < 0.00005), systolic blood 
Table 2. Clinical Features of Subjects With and Without Carotid Atherosclerosis 
Plaque No Plaque p 
(n = 94) (n = 392) Value 
Age (yr) 61 ± 11 49 _+ 12 < 0.00005 
Gender (% male) 63 68 NS 
Body surface area (m 2) 1.87 _+ 0.22 1.88 _+ 0.22 NS 
Body mass index (kg/m z) 25.8 _+ 3.3 26.2 _+ 4.3 NS 
Blood pressure (ram Hg) 
Systolic 145 _+ 27 134 _+ 23 < 0.0005 
Diastolic 83 --- 13 81 _+ 13 NS 
Pulse 62 - 20 52 _+ 14 < 0.0005 
Hypertension (%) 52 41 < 0.05 
Creatinine (mg/dl) 1.0 _+ 0.2 1.0 _+ 0.5 NS 
Glucose (mg/dl) 85 -- 23 86 -- 28 NS 
Total cholesterol (mg/dl) 224 _+ 48 223 _+ 42 NS 
HDL cholesterol (mg/dl) 54 _+ 14 55 -+ 16 NS 
Smoking (%) NS (0.13) 
Former 40 32 
Current 14 11 
Data presented are mean value _+ SD or percent of patients. HDL = high density lipoprotein. 
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Table 3. Cardiac and Vascular Structure of Subjects With and Without Carotid Atherosclerosis 
Plaque No Plaque p 
(n = 94) (n = 392) Value 
LV end-diastolic dimension (cm) 5.0 _+ 0.5 5.0 -+ 0.5 NS 
Septal thickness (cm) 0.96 + 0.13 0.92 _+ 0.13 < 0.005 
Posterior wall thickness (cm) 0.92 _+ 0.12 0.86 _+ 0.12 < 0.00005 
Relative wall thickness 0.37 +_ 0.06 0.35 + 0.06 < 0.001 
LV mass (g) 170 _+ 44 155 + 41 < 0.005 
LV mass index (g/m 2) 91 2-- 19 82 _+ 18 < 0.0001 
Carotid end-diastolic diameter (ram) 5.9 _+ 0.7 5.5 _+ 0.8 < 0.0001 
Carotid wall thickness (mm) 0.88 _+ 0.21 0.76 -+ 0.18 < 0.00005 
Carotid relative wall thickness 0.30 -+ 0.07 0.28 +_ 0.06 < 0.005 
Data presented are mean value _+ SD. LV = left ventricular. 
pressure (127 _+ 14 vs. 120 _+ 11 mm Hg, p < 0.005) and pulse 
pressure (52 + 11 vs. 46 + 8 mm Hg, p < 0.005). There were 
no differences in gender, diastolic pressure or serum lipids, but 
a history of smoking was more common among subjects with 
plaque (60% vs. 43%, p < 0.05). Left ventricular mass index 
was larger in the group with plaque (85 _+ 15 vs. 77 _+ 16 g/m 2, 
p < 0.005) because of significant increases in left ventricular 
wall thicknesses but not chamber diameter. The prevalence of 
left ventricular hypertrophy was higher in the group with 
plaque (11% vs. 2%, p < 0.005). After analysis of covariance 
taking baseline differences in age and blood pressure into 
account, left ventricular mass remained significantly higher in 
the group of normotensive subjects with plaque (162 vs. 146 g, 
Figure 3. Prevalence of atherosclerotic plaque within the extracranial 
carotid arteries was higher among subjects with (15 [35%] of 43) than 
in those without (79 [18%] of 443) echocardiographic evidence of left 
ventricular hypertrophy (LVH). 
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p < 0.02). In a logistic regression analysis, only age (p = 
0.00005) and left ventricular mass (p = 0.01) were indepen- 
dently related to carotid plaque (Table 4). 
Similarly, compared with the 160 hypertensive patients 
without plaque, the 49 patients with plaque were older (62 _+ 
10 vs. 54 _+ 13 years, p < 0.00005) and had higher systolic 
(162 _+ 25 vs. 154 _+ 20 mm Hg, p < 0.05) and pulse (72 + 21 
vs. 61 _ 16 mm Hg, p < 0.0001) pressures but did not differ in 
gender, diastolic blood pressure, serum lipids or smoking 
history. Left ventricular mass was greater in the hypertensive 
patients with plaque (96 -+ 21 vs. 88 _+ 18 g/m 2, p < 0.05) and, 
along with age (p = 0.0002), remained an independent corre- 
late of plaque (p = 0.05) in multivariate analyses involving 
standard risk factors for atherosclerosis (Table 4). 
As a further test of the consistency of results, analyses were 
performed in the 228 subjects drawn from the larger of our 
work site studies (22) and by dividing the subjects into two 
groups on the basis of a median age of 50 years. In all analyses, 
left ventricular mass and mass index were significantly greater 
in the group with than without plaque. 
Discuss ion  
Left ventricular mass and carotid atherosclerosis. We 
believe that the present study provides the first evidence that 
the presence of carotid artery plaque is associated with in- 
creased echocardiographic left ventricular mass and with ven- 
tricular hypertrophy considered as a categoric variable. When 
considered with well established risk factors for extracranial 
carotid atherosclerosis, only age (29,33), left ventricular mass 
index and smoking history are independent predictors of the 
presence of carotid plaque. Furthermore, left ventricular mass 
remained apredictor of carotid plaque in multivariate analyses 
performed in separate normotensive and hypertensive strata of 
our subjects, in the younger and older halves of our study 
subjects and in subjects from a work site-based project with a 
defined sampling strategy as well as in a more selected group of 
adults. The strong association that we observed between 
cerebrovascular therosclerosis and left ventricular mass pro- 
vides a potential pathophysiologic link to explain both the 
increased risk of vascular events, including stroke and transient 
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Table 4. Multivariate Correlates ofCarotid Artery Plaque 
All Subjects (n = 486) Normotensive Subjects (n : 277) 
Beta p Beta 
Coefficient SE Value Coefficient 
Hypertensive Patients (n - 209) 
p Beta p 
SE Value Coefficient SE Value 
Age 0.083 0.014 0.0000 0.088 
Systolic blood pressure -0.005 0.007 0.51 -0.001 
Cholesterol -0.004 0.003 0.22 -0.001 
Left ventricular mass 0.010 0.003 0.005 0.013 
Smoking history 
Former vs. never 0.321 0.292 0.27 0.286 
Current vs. never 0.777 0.401 0.05 0.752 
0.020 0.0000 0.072 0.019 0.0002 
0.018 0.97 -0.007 0.011 0.45 
0.005 0.78 -0.006 0.004 0.17 
0.005 0.01 0.021 0.011 0.05 
0.420 0.50 0.286 0.419 0.50 
0.525 0.51 0.757 0.633 0.23 
ischemic attacks in subjects with ECG or echocardiographic 
left ventricular hypertrophy noted in several previous tudies 
(2-4,17,18,34) and the converse ability of asymptomatic 
carotid bruits to predict cardiac morbid events (35). 
Risk factors for carotid atherosclerosis. Previous popula- 
tion-based studies examining standard risk factors, such as 
serum lipids, cigarette smoking and hypertension, as potential 
determinants of extracranial carotid atherosclerosis have had 
varying results. Among Finnish men studied in Kuopio, smok- 
ing conferred a threefold increase in risk of carotid plaque, 
whereas hypertension was unrelated to atherosclerosis (36). In 
the Rotterdam Elderly Study (37), subjects with isolated 
systolic hypertension had a threefold higher prevalence of 
carotid plaque than age-matched control subjects (15% vs. 
5%) with a similar serum lipid concentration and smoking 
history, but this difference did not achieve statistical signifi- 
cance. In an age-matched case-control analysis from the Ath- 
erosclerosis Risk in Communities (ARIC) Study (38), smoking 
and hypertension were associated with the highest risk for 
carotid atherosclerosis after adjustment for other risk factors. 
An association between carotid plaque and hypertension has 
been more consistently observed in studies of clinical series of 
largely symptomatic patients (39-41). 
Figure 4. Prevalence of atherosclerotic plaque within the extracranial 
carotid arteries increased significantly (p < 0.005) from the lowest 
quintile of left ventricular (LV) mass index (<68.5 g/m 2) to the highest 
(>97.6 g/m2). 
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In the present study of asymptomatic normotensive and 
hypertensive subjects, most of whom were recruited from work 
site-based populations, subjects differed from those without 
carotid plaque in age, systolic and pulse pressures, as well as 
the prevalence of hypertension among traditional risk factors. 
Our finding that age and smoking history among traditional 
risk factors were independent predictors of carotid atheroscle- 
rosis in multivariate analyses i also compatible with the results 
of previous tudies. The elimination of arterial pressure as an 
independent predictor of carotid plaque in an analysis that also 
considered left ventricular mass may reflect he known positive 
relation between blood pressure and ventricular mass and the 
possibility suggested by studies using ambulatory pressure 
monitoring that left ventricular mass may be a better measure 
of long-term blood pressure than are rest blood pressure 
measurements themselves (42). 
The lack of a significant difference in the present study in 
serum lipids between subjects with and without plaque may be 
attributable to a variety of factors, including their healthy, 
asymptomatic status; the relatively low mean level of serum 
cholesterol; the inclusion of a significant proportion of women 
(43); and the possibility that recent shifts in diet may have 
reduced lipid levels in some subjects from those that prevailed 
during the protracted process of development of atheroma. 
Mechanism of association. The mechanism underlying the 
association between left ventricular hypertrophy and carotid 
atherosclerosis uncertain. Similar to the results of the 
present study, we recently reported (30) parallel increases in 
ventricular and vascular wall thicknesses in hypertensive pa- 
tients, which, although related to blood pressure, remained 
significant independently of age and conventional blood pres- 
sure measurements, suggesting that additional factors promote 
cardiac and vascular growth. However, the impact of arterial 
pressure on both organs may have been underestimated as a 
result of the known limitations of rest as opposed to ambula- 
tory measurements of blood pressure levels (42). Alternatively, 
changes in arterial properties due to vascular growth or 
atherosclerosis may cause earlier eturn of reflected pressure 
waves to the central circulation or elevation of effective arterial 
elastance that may stimulate increases in left ventricular mass 
and relative wall thickness (44,45) without a detectable alter- 
ation in systolic or diastolic arterial pressure. The increased 
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carotid wall thickness in a segment unaffected by discrete 
atheroma inour subjects with plaque may represent either the 
vascular hypertrophy that we have found to be associated with 
these abnormalities of arterial dynamics or early generalized 
atherosclerosis (46,47). Although ypertension is a risk factor 
for the development of stroke, the striking increase in risk 
associated with left ventricular hypertrophy appears to be 
independent of conventional blood pressure measurements 
(17,18). 
In addition to these hemodynamic mechanisms, it is possi- 
ble that asymptomatic coronary atherosclerosis--which would 
be expected to be more prevalent in patients with carotid 
atherosclerosis (39)--might have contributed to the develop- 
ment of increased left ventricular mass in our patients with 
carotid plaque. Thus, transient experimental coronary occlu- 
sion stimulates myocardial growth (48), and clinical studies 
document increased ventricular mass in patients with coronary 
stenoses (7,49,50). Given the strong association between ca- 
rotid plaque and subsequent myocardial infarction in the 
Kuopio Heart Disease Risk Factor Study (51,52), our findings 
may provide a noninvasive window on more generalized ath- 
erosclerosis n subjects with left ventricular hypertrophy. 
Clinical implications. Several potential clinical implica- 
tions of the present study need to be clarified by longitudinal 
study. Whether subjects with both asymptomatic carotid ath- 
erosclerosis and abnormal left ventricular geometry are at 
higher isk than those with either abnormality alone needs to 
be verified by long-term follow-up. Other studies examining 
the prognostic importance of echocardiographic left ventricu- 
lar hypertrophy ave provided little (4) or no data (6) concern- 
ing the risk of developing symptomatic cerebrovascular dis- 
ease. Similarly, initial reports of the ability of atherosclerosis in 
the carotid circulation detected by ultrasound to predict myo- 
cardial infarction (51,52) have not considered left ventricular 
mass as a covariate predisposing to this adverse outcome. At 
present, detection of cardiac or vascular abnormalities indica- 
tive of preclinical cardiovascular disease (44,53) often prompts 
intervention aimed at reversing or at least retarding progres- 
sion of morphologic abnormalities by lowering blood pressure 
or serum lipids, cessation of smoking or dietary change to 
reduce salt intake or induce weight loss. Although the impact 
of normalization of left ventricular mass or regression of 
carotid atherosclerosis on clinical outcome has not been 
conclusively established, preliminary data (54) suggest hat 
normalization of left ventricular mass by antihypertensive 
treatment is associated with a reduced risk of subsequent 
events. 
Study limitations. A potential limitation of the current 
study concerns the previous use of pharmacologic agents to 
lower blood pressure in a substantial proportion of the hyper- 
tensive patients because several classes of antihypertensive 
agents have been shown to reduce left ventricular mass over 
periods as short as several months (55). A reduction in left 
ventricular mass among previously treated hypertensive pa- 
tients might be expected to weaken the association of carotid 
atherosclerosis with left ventricular hypertrophy because such 
treatment would be expected to have a much slower, if any, 
effect on the presence of plaque. This suggests that the 
observed association between atherosclerosis and left ventric- 
ular mass may have been understated. 
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